Anti-CCP (Anti-Cyclic Citrullinated Peptide)

The Anti-CCP test may be ordered along with or following a rheumatoid factor (RF) test to help diagnose rheumatoid arthritis (RA). CCP may also be ordered to help evaluate the likely development of RA in patients with undifferentiated arthritis those whose symptoms suggest but do not yet meet the American College of Rheumatology criteria for RA. According to American College of Rheumatology, approximately 95% of patients with a positive CCP test will develop RA in the future.

Aalto’s Anti-CCP controls are intended for use in monitoring the performance of laboratory assays for Anti-CCP.